{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T03:57:24Z","timestamp":1794542244503,"version":"4.9.1"},"reference-count":145,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,6,17]],"date-time":"2020-06-17T00:00:00Z","timestamp":1592352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,17]],"date-time":"2020-06-17T00:00:00Z","timestamp":1592352000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Biomed Sci"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Pulmonary diseases due to mycobacteria cause significant morbidity and mortality to human health. In addition to tuberculosis (TB), caused by\n                    <jats:italic>Mycobacterium tuberculosis<\/jats:italic>\n                    (Mtb), recent epidemiological studies have shown the emergence of non-tuberculous mycobacteria (NTM) species in causing lung diseases in humans. Although more than 170 NTM species are present in various environmental niches, only a handful, primarily\n                    <jats:italic>Mycobacterium avium<\/jats:italic>\n                    complex and\n                    <jats:italic>M. abscessus<\/jats:italic>\n                    , have been implicated in pulmonary disease. While TB is transmitted through inhalation of aerosol droplets containing Mtb, generated by patients with symptomatic disease, NTM disease is mostly disseminated through aerosols originated from the environment. However, following inhalation, both Mtb and NTM are phagocytosed by alveolar macrophages in the lungs. Subsequently, various immune cells are recruited from the circulation to the site of infection, which leads to granuloma formation. Although the pathophysiology of TB and NTM diseases share several fundamental cellular and molecular events, the host-susceptibility to Mtb and NTM infections are different. Striking differences also exist in the disease presentation between TB and NTM cases. While NTM disease is primarily associated with bronchiectasis, this condition is rarely a predisposing factor for TB. Similarly, in Human Immunodeficiency Virus (HIV)-infected individuals, NTM disease presents as disseminated, extrapulmonary form rather than as a miliary, pulmonary disease, which is seen in Mtb infection. The diagnostic modalities for TB, including molecular diagnosis and drug-susceptibility testing (DST), are more advanced and possess a higher rate of sensitivity and specificity, compared to the tools available for NTM infections. In general, drug-sensitive TB is effectively treated with a standard multi-drug regimen containing well-defined first- and second-line antibiotics. However, the treatment of drug-resistant TB requires the additional, newer class of antibiotics in combination with or without the first and second-line drugs. In contrast, the NTM species display significant heterogeneity in their susceptibility to standard anti-TB drugs. Thus, the treatment for NTM diseases usually involves the use of macrolides and injectable aminoglycosides. Although well-established international guidelines are available, treatment of NTM disease is mostly empirical and not entirely successful. In general, the treatment duration is much longer for NTM diseases, compared to TB, and resection surgery of affected organ(s) is part of treatment for patients with NTM diseases that do not respond to the antibiotics treatment. Here, we discuss the epidemiology, diagnosis, and treatment modalities available for TB and NTM diseases of humans.\n                  <\/jats:p>","DOI":"10.1186\/s12929-020-00667-6","type":"journal-article","created":{"date-parts":[[2020,6,17]],"date-time":"2020-06-17T00:02:29Z","timestamp":1592352149000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":331,"title":["Of tuberculosis and non-tuberculous mycobacterial infections \u2013 a comparative analysis of epidemiology, diagnosis and treatment"],"prefix":"10.1186","volume":"27","author":[{"given":"Radha","family":"Gopalaswamy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sivakumar","family":"Shanmugam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh","family":"Mondal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2021-8632","authenticated-orcid":false,"given":"Selvakumar","family":"Subbian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,17]]},"reference":[{"key":"667_CR1","volume-title":"Global tuberculosis report 2019","author":"WHO","year":"2019","unstructured":"WHO. Global tuberculosis report 2019. 2019. https:\/\/www.who.int\/tb\/publications\/global_report\/en\/. Accessed."},{"issue":"suppl_6","key":"667_CR2","doi-asserted-by":"publisher","first-page":"S629","DOI":"10.1093\/infdis\/jix362","volume":"216","author":"G Churchyard","year":"2017","unstructured":"Churchyard G, Kim P, Shah NS, Rustomjee R, Gandhi N, Mathema B, Dowdy D, Kasmar A, Cardenas V. What we know about tuberculosis transmission: an overview. J Infect Dis. 2017;216(suppl_6):S629\u201335.","journal-title":"J Infect Dis"},{"issue":"10024","key":"667_CR3","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1016\/S0140-6736(15)00151-8","volume":"387","author":"K Dheda","year":"2016","unstructured":"Dheda K, Barry CE 3rd, Maartens G. Tuberculosis. Lancet. 2016;387(10024):1211\u201326.","journal-title":"Lancet"},{"issue":"6","key":"667_CR4","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1093\/cid\/cir951","volume":"54","author":"JR Andrews","year":"2012","unstructured":"Andrews JR, Noubary F, Walensky RP, Cerda R, Losina E, Horsburgh CR. Risk of progression to active tuberculosis following reinfection with Mycobacterium tuberculosis. Clin Infect Dis. 2012;54(6):784\u201391.","journal-title":"Clin Infect Dis."},{"issue":"3","key":"667_CR5","first-page":"210","volume":"6","author":"MM Johnson","year":"2014","unstructured":"Johnson MM, Odell JA. Non-tuberculous mycobacterial pulmonary infections. J Thorac Dis. 2014;6(3):210\u201320.","journal-title":"J Thorac Dis."},{"issue":"4","key":"667_CR6","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1164\/rccm.200604-571ST","volume":"175","author":"DE Griffith","year":"2007","unstructured":"Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, Holland SM, Horsburgh R, Huitt G, Iademarco MF, Iseman M, Olivier K, Ruoss S, von Reyn CF, Wallace RJ Jr, Winthrop K, Subcommittee A.T.S.M.D., American Thoracic S. and infectious disease society of A. An official ATS\/IDSA statement: diagnosis, treatment, and prevention of non-tuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007;175(4):367\u2013416.","journal-title":"Am J Respir Crit Care Med."},{"issue":"10","key":"667_CR7","first-page":"554","volume":"53","author":"GS Martinez","year":"2017","unstructured":"Martinez GS, Cano CA, Sota Yoldi LA, Garcia Garcia JM, Alba Alvarez LM, Palacios Gutierrez JJ. en representacion de la Red de Laboratorios de Microbiologia del S. Non-tuberculous mycobacteria. an emerging threat? Arch Bronconeumol. 2017;53(10):554\u201360.","journal-title":"Arch Bronconeumol."},{"issue":"1","key":"667_CR8","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/resp.13143","volume":"23","author":"K Dheda","year":"2018","unstructured":"Dheda K, Cox H, Esmail A, Wasserman S, Chang KC, Lange C. Recent controversies about MDR and XDR-TB: Global implementation of the WHO shorter MDR-TB regimen and bedaquiline for all with MDR-TB? Respirology. 2018;23(1):36\u201345.","journal-title":"Respirology."},{"issue":"10","key":"667_CR9","doi-asserted-by":"publisher","first-page":"e93","DOI":"10.1164\/rccm.201909-1874ST","volume":"200","author":"P Nahid","year":"2019","unstructured":"Nahid P, Mase SR, Migliori GB, Sotgiu G, Bothamley GH, Brozek JL, Cattamanchi A, Cegielski JP, Chen L, Daley CL, Dalton TL, Duarte R, Fregonese F, Horsburgh CR Jr, Ahmad Khan F, Kheir F, Lan Z, Lardizabal A, Lauzardo M, Mangan JM, Marks SM, McKenna L, Menzies D, Mitnick CD, Nilsen DM, Parvez F, Peloquin CA, Raftery A, Schaaf HS, Shah NS, Starke JR, Wilson JW, Wortham JM, Chorba T, Seaworth B. Treatment of drug-resistant tuberculosis. an official ATS\/CDC\/ERS\/IDSA clinical practice guideline. Am J Respir Crit Care Med. 2019;200(10):e93\u2013e142.","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"667_CR10","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1016\/j.drudis.2018.04.001","volume":"23","author":"ML Wu","year":"2018","unstructured":"Wu ML, Aziz DB, Dartois V, Dick T. NTM drug discovery: status, gaps and the way forward. Drug Discov Today. 2018;23(8):1502\u201319.","journal-title":"Drug Discov Today."},{"issue":"1","key":"667_CR11","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1055\/s-0033-1333573","volume":"34","author":"ED Chan","year":"2013","unstructured":"Chan ED, Iseman MD. Underlying host risk factors for non-tuberculous mycobacterial lung disease. Semin Respir Crit Care Med. 2013;34(1):110\u201323.","journal-title":"Semin Respir Crit Care Med."},{"issue":"1","key":"667_CR12","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/imr.12266","volume":"264","author":"G Weiss","year":"2015","unstructured":"Weiss G, Schaible UE. Macrophage defense mechanisms against intracellular bacteria. Immunol Rev. 2015;264(1):182\u2013203.","journal-title":"Immunol Rev."},{"issue":"7","key":"667_CR13","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1164\/rccm.201003-0503OC","volume":"182","author":"KL Winthrop","year":"2010","unstructured":"Winthrop KL, McNelley E, Kendall B, Marshall-Olson A, Morris C, Cassidy M, Saulson A, Hedberg K. Pulmonary non-tuberculous mycobacterial disease prevalence and clinical features: an emerging public health disease. Am J Respir Crit Care Med. 2010;182(7):977\u201382.","journal-title":"Am J Respir Crit Care Med."},{"key":"667_CR14","volume-title":"Epidemiology of tuberculosis","author":"CDC A","year":"2019","unstructured":"CDC A. Epidemiology of tuberculosis. 2019. https:\/\/www.cdc.gov\/tb\/education\/ssmodules\/pdfs\/Module2.pdf. Accessed."},{"issue":"2","key":"667_CR15","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1128\/CMR.9.2.177","volume":"9","author":"JO Falkinham 3rd","year":"1996","unstructured":"Falkinham JO 3rd. Epidemiology of infection by non-tuberculous mycobacteria. Clin Microbiol Rev. 1996;9(2):177\u2013215.","journal-title":"Clin Microbiol Rev."},{"issue":"1","key":"667_CR16","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1186\/s12879-019-4412-6","volume":"19","author":"C Hu","year":"2019","unstructured":"Hu C, Huang L, Cai M, Wang W, Shi X, Chen W. Characterization of non-tuberculous mycobacterial pulmonary disease in Nanjing district of China. BMC Infect Dis. 2019;19(1):764.","journal-title":"BMC Infect Dis."},{"issue":"7","key":"667_CR17","doi-asserted-by":"publisher","first-page":"e152","DOI":"10.1371\/journal.pmed.0050152","volume":"5","author":"CY Jeon","year":"2008","unstructured":"Jeon CY, Murray MB. Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies. PLoS Med. 2008;5(7):e152.","journal-title":"PLoS Med."},{"issue":"7","key":"667_CR18","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1111\/bcp.13935","volume":"85","author":"NC Lutfiana","year":"2019","unstructured":"Lutfiana NC, van Boven JFM, Masoom Zubair MA, Pena MJ, Alffenaar JC. Diabetes mellitus co-morbidity in patients enrolled in tuberculosis drug efficacy trials around the world: A systematic review. Br J Clin Pharmacol. 2019;85(7):1407\u201317.","journal-title":"Br J Clin Pharmacol."},{"issue":"2","key":"667_CR19","first-page":"100","volume":"17","author":"E Mortaz","year":"2018","unstructured":"Mortaz E, Moloudizargari M, Varahram M, Movassaghi M, Garssen J, Kazempour DM, Mirsaeidi M, Adcock IM. What Immunological Defects Predispose to Non-tuberculosis Mycobacterial Infections? Iran J Allergy Asthma Immunol. 2018;17(2):100\u20139.","journal-title":"Iran J Allergy Asthma Immunol."},{"issue":"6","key":"667_CR20","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1097\/COH.0000000000000495","volume":"13","author":"JA Tornheim","year":"2018","unstructured":"Tornheim JA, Dooley KE. Challenges of TB and HIV co-treatment: updates and insights. Curr Opin HIV AIDS. 2018;13(6):486\u201391.","journal-title":"Curr Opin HIV AIDS."},{"issue":"1","key":"667_CR21","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1186\/s12879-019-3909-3","volume":"19","author":"ZX Zhang","year":"2019","unstructured":"Zhang ZX, Cherng BPZ, Sng LH, Tan YE. Clinical and microbiological characteristics of non-tuberculous mycobacteria diseases in Singapore with a focus on pulmonary disease, 2012-2016. BMC Infect Dis. 2019;19(1):436.","journal-title":"BMC Infect Dis."},{"issue":"9","key":"667_CR22","doi-asserted-by":"publisher","first-page":"e0138070","DOI":"10.1371\/journal.pone.0138070","volume":"10","author":"Z Grozdanovic","year":"2015","unstructured":"Grozdanovic Z, Berrocal Almanza LC, Goyal S, Hussain A, Klassert TE, Driesch D, Tokaryeva V, Loschmann YY, Sumanlatha G, Ahmed N, Valluri V, Schumann RR, Lala B, Slevogt H. A Novel Reading Scheme for Assessing the Extent of Radiographic Abnormalities and Its Association with Disease Severity in Sputum Smear-Positive Tuberculosis: An Observational Study in Hyderabad\/India. PLoS One. 2015;10(9):e0138070.","journal-title":"PLoS One."},{"issue":"2","key":"667_CR23","doi-asserted-by":"publisher","first-page":"74","DOI":"10.4046\/trd.2016.79.2.74","volume":"79","author":"YJ Ryu","year":"2016","unstructured":"Ryu YJ, Koh WJ, Daley CL. Diagnosis and Treatment of Nontuberculous Mycobacterial Lung Disease: Clinicians' Perspectives. Tuberc Respir Dis (Seoul). 2016;79(2):74\u201384.","journal-title":"Tuberc Respir Dis (Seoul)."},{"key":"667_CR24","volume-title":"Global Tuberculosis Programme. Laboratory services in tuberculosis control. Part II: microscopy","author":"WHO","year":"1998","unstructured":"WHO. Global Tuberculosis Programme. Laboratory services in tuberculosis control. Part II: microscopy. 1998. https:\/\/www.who.int\/tb\/publications\/who_tb_98_258\/en\/. Accessed."},{"key":"667_CR25","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jctube.2016.05.005","volume":"4","author":"AJ Caulfield","year":"2016","unstructured":"Caulfield AJ, Wengenack NL. Diagnosis of active tuberculosis disease: From microscopy to molecular techniques. J Clin Tuberc Other Mycobact Dis. 2016;4:33\u201343.","journal-title":"J Clin Tuberc Other Mycobact Dis."},{"issue":"2","key":"667_CR26","doi-asserted-by":"publisher","first-page":"89","DOI":"10.4103\/0974-2727.72157","volume":"2","author":"B Sharma","year":"2010","unstructured":"Sharma B, Pal N, Malhotra B, Vyas L. Evaluation of a Rapid Differentiation Test for Mycobacterium Tuberculosis from other Mycobacteria by Selective Inhibition with p-nitrobenzoic Acid using MGIT 960. J Lab Physicians. 2010;2(2):89\u201392.","journal-title":"J Lab Physicians."},{"issue":"2","key":"667_CR27","first-page":"92","volume":"59","author":"S Kanade","year":"2012","unstructured":"Kanade S, Nataraj G, Suryawanshi R, Mehta P. Utility of MPT 64 antigen detection assay for rapid characterization of mycobacteria in a resource constrained setting. Indian J Tuberc. 2012;59(2):92\u20136.","journal-title":"Indian J Tuberc."},{"issue":"4","key":"667_CR28","first-page":"DC13","volume":"8","author":"VP Shenoy","year":"2014","unstructured":"Shenoy VP, Mukhopadhyay C. Rapid Immunochromatographic Test for the Identification and Discrimination of Mycobacterium tuberculosis Complex Isolates from Non-tuberculous Mycobacteria. J Clin Diagn Res. 2014;8(4):DC13\u20135.","journal-title":"J Clin Diagn Res."},{"issue":"10","key":"667_CR29","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1309\/LMDDEHPSYE6ZDM3C","volume":"42","author":"J Jeong","year":"2011","unstructured":"Jeong J, Kim SR, Lee SH, Lim JH, Choi JI, Park JS, Chang CL, Choi JY, Richman DD, Smith DM. The Use of High Performance Liquid Chromatography to Speciate and Characterize the Epidemiology of Mycobacteria. Lab Med. 2011;42(10):612\u20137.","journal-title":"Lab Med."},{"issue":"1","key":"667_CR30","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1111\/jam.13604","volume":"124","author":"G Sebastian","year":"2018","unstructured":"Sebastian G, Nagaraja SB, Vishwanatha T, Voderhobli M, Vijayalakshmi N, Kumar P. Non-Tuberculosis mycobacterium speciation using HPLC under Revised National TB Control Programme (RNTCP) in India. J Appl Microbiol. 2018;124(1):267\u201373.","journal-title":"J Appl Microbiol."},{"key":"667_CR31","first-page":"349","volume":"101","author":"P Kirschner","year":"1998","unstructured":"Kirschner P, Bottger EC. Species identification of mycobacteria using rDNA sequencing. Methods Mol Biol. 1998;101:349\u201361.","journal-title":"Methods Mol Biol."},{"issue":"7","key":"667_CR32","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1128\/JCM.30.7.1815-1822.1992","volume":"30","author":"BB Plikaytis","year":"1992","unstructured":"Plikaytis BB, Plikaytis BD, Yakrus MA, Butler WR, Woodley CL, Silcox VA, Shinnick TM. Differentiation of slowly growing Mycobacterium species, including Mycobacterium tuberculosis, by gene amplification and restriction fragment length polymorphism analysis. J Clin Microbiol. 1992;30(7):1815\u201322.","journal-title":"J Clin Microbiol."},{"issue":"2","key":"667_CR33","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cll.2014.03.001","volume":"34","author":"A Somoskovi","year":"2014","unstructured":"Somoskovi A, Salfinger M. Nontuberculous mycobacteria in respiratory infections: advances in diagnosis and identification. Clin Lab Med. 2014;34(2):271\u201395.","journal-title":"Clin Lab Med."},{"issue":"2","key":"667_CR34","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1128\/JCM.31.2.175-178.1993","volume":"31","author":"A Telenti","year":"1993","unstructured":"Telenti A, Marchesi F, Balz M, Bally F, Bottger EC, Bodmer T. Rapid identification of mycobacteria to the species level by polymerase chain reaction and restriction enzyme analysis. J Clin Microbiol. 1993;31(2):175\u20138.","journal-title":"J Clin Microbiol."},{"issue":"12","key":"667_CR35","doi-asserted-by":"publisher","first-page":"3106","DOI":"10.1128\/JCM.33.12.3106-3110.1995","volume":"33","author":"E Carpentier","year":"1995","unstructured":"Carpentier E, Drouillard B, Dailloux M, Moinard D, Vallee E, Dutilh B, Maugein J, Bergogne-Berezin E, Carbonnelle B. Diagnosis of tuberculosis by Amplicor Mycobacterium tuberculosis test: a multicenter study. J Clin Microbiol. 1995;33(12):3106\u201310.","journal-title":"J Clin Microbiol."},{"issue":"2","key":"667_CR36","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1128\/JCM.02209-13","volume":"52","author":"P Castan","year":"2014","unstructured":"Castan P, de Pablo A, Fernandez-Romero N, Rubio JM, Cobb BD, Mingorance J, Toro C. Point-of-care system for detection of Mycobacterium tuberculosis and rifampin resistance in sputum samples. J Clin Microbiol. 2014;52(2):502\u20137.","journal-title":"J Clin Microbiol."},{"issue":"2","key":"667_CR37","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1097\/00001432-200304000-00003","volume":"16","author":"K Chemlal","year":"2003","unstructured":"Chemlal K, Portaels F. Molecular diagnosis of non-tuberculous mycobacteria. Curr Opin Infect Dis. 2003;16(2):77\u201383.","journal-title":"Curr Opin Infect Dis."},{"issue":"3","key":"667_CR38","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1128\/JCM.41.3.948-953.2003","volume":"41","author":"DW Dowdy","year":"2003","unstructured":"Dowdy DW, Maters A, Parrish N, Beyrer C, Dorman SE. Cost-effectiveness analysis of the gen-probe amplified mycobacterium tuberculosis direct test as used routinely on smear-positive respiratory specimens. J Clin Microbiol. 2003;41(3):948\u201353.","journal-title":"J Clin Microbiol."},{"issue":"3","key":"667_CR39","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1128\/JCM.01528-08","volume":"47","author":"R Fang","year":"2009","unstructured":"Fang R, Li X, Hu L, You Q, Li J, Wu J, Xu P, Zhong H, Luo Y, Mei J, Gao Q. Cross-priming amplification for rapid detection of Mycobacterium tuberculosis in sputum specimens. J Clin Microbiol. 2009;47(3):845\u20137.","journal-title":"J Clin Microbiol."},{"issue":"4","key":"667_CR40","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.diagmicrobio.2017.08.016","volume":"89","author":"Y Igarashi","year":"2017","unstructured":"Igarashi Y, Chikamatsu K, Aono A, Yi L, Yamada H, Takaki A, Mitarai S. Laboratory evaluation of the Anyplex II MTB\/MDR and MTB\/XDR tests based on multiplex real-time PCR and melting-temperature analysis to identify Mycobacterium tuberculosis and drug resistance. Diagn Microbiol Infect Dis. 2017;89(4):276\u201381.","journal-title":"Diagn Microbiol Infect Dis."},{"issue":"9","key":"667_CR41","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.2217\/fmb.11.84","volume":"6","author":"SD Lawn","year":"2011","unstructured":"Lawn SD, Nicol MP. Xpert(R) MTB\/RIF assay: development, evaluation and implementation of a new rapid molecular diagnostic for tuberculosis and rifampicin resistance. Future Microbiol. 2011;6(9):1067\u201382.","journal-title":"Future Microbiol."},{"issue":"2","key":"667_CR42","doi-asserted-by":"publisher","first-page":"111","DOI":"10.7774\/cevr.2018.7.2.111","volume":"7","author":"S Lee","year":"2018","unstructured":"Lee S, Hwang KA, Ahn JH, Nam JH. Evaluation of EZplex MTBC\/NTM Real-Time PCR kit: diagnostic accuracy and efficacy in vaccination. Clin Exp Vaccine Res. 2018;7(2):111\u20138.","journal-title":"Clin Exp Vaccine Res."},{"issue":"3","key":"667_CR43","doi-asserted-by":"publisher","first-page":"e0228312","DOI":"10.1371\/journal.pone.0228312","volume":"15","author":"X Ou","year":"2020","unstructured":"Ou X, Li Q, Su D, Xia H, Wang S, Zhao B, Zhao Y. A pilot study: VereMTB detection kit for rapid detection of multidrug-resistant mycobcterium tuberculosis in clinical sputum samples. PLoS One. 2020;15(3):e0228312.","journal-title":"PLoS One."},{"key":"667_CR44","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.mimet.2017.05.006","volume":"139","author":"F Perez-Garcia","year":"2017","unstructured":"Perez-Garcia F, Ruiz-Serrano MJ, Lopez RP, Acosta F, Perez-Lago L, Garcia-De-Viedma D, Bouza E. Diagnostic performance of Anyplex II MTB\/MDR\/XDR for detection of resistance to first and second line drugs in Mycobacterium tuberculosis. J Microbiol Methods. 2017;139:74\u20138.","journal-title":"J Microbiol Methods."},{"issue":"1","key":"667_CR45","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1128\/JCM.01904-15","volume":"54","author":"M Sali","year":"2016","unstructured":"Sali M, De Maio F, Caccuri F, Campilongo F, Sanguinetti M, Fiorentini S, Delogu G, Giagulli C. Multicenter Evaluation of Anyplex Plus MTB\/NTM MDR-TB Assay for Rapid Detection of Mycobacterium tuberculosis Complex and Multidrug-Resistant Isolates in Pulmonary and Extrapulmonary Specimens. J Clin Microbiol. 2016;54(1):59\u201363.","journal-title":"J Clin Microbiol."},{"issue":"4","key":"667_CR46","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1128\/JCM.02847-15","volume":"54","author":"S Shenai","year":"2016","unstructured":"Shenai S, Armstrong DT, Valli E, Dolinger DL, Nakiyingi L, Dietze R, Dalcolmo MP, Nicol MP, Zemanay W, Manabe Y, Hadad DJ, Marques-Rodrigues P, Palaci M, Peres RL, Gaeddert M, Armakovitch S, Nonyane BA, Denkinger CM, Banada P, Joloba ML, Ellner J, Boehme C, Alland D, Dorman SE. Analytical and Clinical Evaluation of the Epistem Genedrive Assay for Detection of Mycobacterium tuberculosis. J Clin Microbiol. 2016;54(4):1051\u20137.","journal-title":"J Clin Microbiol."},{"issue":"1","key":"667_CR47","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1186\/s12879-019-3881-y","volume":"19","author":"PB Shete","year":"2019","unstructured":"Shete PB, Farr K, Strnad L, Gray CM, Cattamanchi A. Diagnostic accuracy of TB-LAMP for pulmonary tuberculosis: a systematic review and meta-analysis. BMC Infect Dis. 2019;19(1):268.","journal-title":"BMC Infect Dis."},{"issue":"2","key":"667_CR48","doi-asserted-by":"publisher","first-page":"169","DOI":"10.3343\/alm.2020.40.2.169","volume":"40","author":"S Shin","year":"2020","unstructured":"Shin S, Yoo IY, Shim HJ, Kang OK, Jhun BW, Koh WJ, Huh HJ, Lee NY. Diagnostic Performance of the GENEDIA MTB\/NTM Detection Kit for Detecting Mycobacterium tuberculosis and Nontuberculous Mycobacteria With Sputum Specimens. Ann Lab Med. 2020;40(2):169\u201373.","journal-title":"Ann Lab Med."},{"issue":"3","key":"667_CR49","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/S0272-5231(02)00018-7","volume":"23","author":"A Somoskovi","year":"2002","unstructured":"Somoskovi A, Mester J, Hale YM, Parsons LM, Salfinger M. Laboratory diagnosis of non-tuberculous mycobacteria. Clin Chest Med. 2002;23(3):585\u201397.","journal-title":"Clin Chest Med."},{"key":"667_CR50","volume-title":"Automated real-time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance: Xpert MTB\/RIF system. Policy statement","author":"WHO","year":"2011","unstructured":"WHO. Automated real-time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance: Xpert MTB\/RIF system. Policy statement. 2011. http:\/\/apps.who.int\/iris\/handle\/10665\/44586. Accessed."},{"key":"667_CR51","volume-title":"Next-generation Xpert\u00ae MTB\/RIF Ultra assay recommended by WHO","author":"WHO","year":"2017","unstructured":"WHO. Next-generation Xpert\u00ae MTB\/RIF Ultra assay recommended by WHO. 2017."},{"key":"667_CR52","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/srep00246","volume":"2","author":"G Xu","year":"2012","unstructured":"Xu G, Hu L, Zhong H, Wang H, Yusa S, Weiss TC, Romaniuk PJ, Pickerill S, You Q. Cross priming amplification: mechanism and optimization for isothermal DNA amplification. Sci Rep. 2012;2:246.","journal-title":"Sci Rep."},{"key":"667_CR53","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.ijid.2019.09.016","volume":"90","author":"M Zhang","year":"2020","unstructured":"Zhang M, Xue M, He JQ. Diagnostic accuracy of the new Xpert MTB\/RIF Ultra for tuberculosis disease: A preliminary systematic review and meta-analysis. Int J Infect Dis. 2020;90:35\u201345.","journal-title":"Int J Infect Dis."},{"issue":"5","key":"667_CR54","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1111\/j.1469-0691.2006.01380.x","volume":"12","author":"J Makinen","year":"2006","unstructured":"Makinen J, Marjamaki M, Marttila H, Soini H. Evaluation of a novel strip test, GenoType Mycobacterium CM\/AS, for species identification of mycobacterial cultures. Clin Microbiol Infect. 2006;12(5):481\u20133.","journal-title":"Clin Microbiol Infect."},{"issue":"6","key":"667_CR55","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1128\/JCM.41.6.2672-2675.2003","volume":"41","author":"E Richter","year":"2003","unstructured":"Richter E, Weizenegger M, Rusch-Gerdes S, Niemann S. Evaluation of genotype MTBC assay for differentiation of clinical Mycobacterium tuberculosis complex isolates. J Clin Microbiol. 2003;41(6):2672\u20135.","journal-title":"J Clin Microbiol."},{"issue":"8","key":"667_CR56","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1007\/s10096-004-1168-7","volume":"23","author":"A Sarkola","year":"2004","unstructured":"Sarkola A, Makinen J, Marjamaki M, Marttila HJ, Viljanen MK, Soini H. Prospective evaluation of the GenoType assay for routine identification of mycobacteria. Eur J Clin Microbiol Infect Dis. 2004;23(8):642\u20135.","journal-title":"Eur J Clin Microbiol Infect Dis."},{"issue":"12","key":"667_CR57","doi-asserted-by":"publisher","first-page":"4477","DOI":"10.1128\/JCM.39.12.4477-4482.2001","volume":"39","author":"PN Suffys","year":"2001","unstructured":"Suffys PN, da Silva RA, de Oliveira M, Campos CE, Barreto AM, Portaels F, Rigouts L, Wouters G, Jannes G, van Reybroeck G, Mijs W, Vanderborght B. Rapid identification of Mycobacteria to the species level using INNO-LiPA Mycobacteria, a reverse hybridization assay. J Clin Microbiol. 2001;39(12):4477\u201382.","journal-title":"J Clin Microbiol."},{"issue":"3","key":"667_CR58","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1128\/JCM.39.3.1079-1084.2001","volume":"39","author":"E Tortoli","year":"2001","unstructured":"Tortoli E, Nanetti A, Piersimoni C, Cichero P, Farina C, Mucignat G, Scarparo C, Bartolini L, Valentini R, Nista D, Gesu G, Tosi CP, Crovatto M, Brusarosco G. Performance assessment of new multiplex probe assay for identification of mycobacteria. J Clin Microbiol. 2001;39(3):1079\u201384.","journal-title":"J Clin Microbiol."},{"key":"667_CR59","doi-asserted-by":"crossref","unstructured":"Doyle RM, Burgess C, Williams R, Gorton R, Booth H, Brown J, Bryant JM, Chan J, Creer D, Holdstock J, Kunst H, Lozewicz S, Platt G, Romero EY, Speight G, Tiberi S, Abubakar I, Lipman M, McHugh TD, Breuer J. Direct whole-genome sequencing of sputum accurately identifies drug-resistant mycobacterium tuberculosis faster than MGIT culture sequencing. J Clin Microbiol. 2018;56(8).","DOI":"10.1128\/JCM.00666-18"},{"issue":"3","key":"667_CR60","first-page":"214","volume":"41","author":"GE Genc","year":"2018","unstructured":"Genc GE, Demir M, Yaman G, Kayar B, Koksal F, Satana D. Evaluation of MALDI-TOF MS for identification of non-tuberculous mycobacteria isolated from clinical specimens in mycobacteria growth indicator tube medium. New Microbiol. 2018;41(3):214\u20139.","journal-title":"New Microbiol."},{"key":"667_CR61","doi-asserted-by":"publisher","first-page":"854078","DOI":"10.1155\/2015\/854078","volume":"2015","author":"MC Mediavilla-Gradolph","year":"2015","unstructured":"Mediavilla-Gradolph MC, De Toro-Peinado I, Bermudez-Ruiz MP, Garcia-Martinez ML, Ortega-Torres M, Montiel Q-GN, Palop-Borras B. Use of MALDI-TOF MS for Identification of Nontuberculous Mycobacterium Species Isolated from Clinical Specimens. Biomed Res Int. 2015;2015:854078.","journal-title":"Biomed Res Int."},{"key":"667_CR62","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/5584_2017_26","volume":"1021","author":"M Neuschlova","year":"2017","unstructured":"Neuschlova M, Vladarova M, Kompanikova J, Sadlonova V, Novakova E. Identification of Mycobacterium Species by MALDI-TOF Mass Spectrometry. Adv Exp Med Biol. 2017;1021:37\u201342.","journal-title":"Adv Exp Med Biol."},{"key":"667_CR63","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.ijid.2017.07.007","volume":"62","author":"C Nimmo","year":"2017","unstructured":"Nimmo C, Doyle R, Burgess C, Williams R, Gorton R, McHugh TD, Brown M, Morris-Jones S, Booth H, Breuer J. Rapid identification of a Mycobacterium tuberculosis full genetic drug resistance profile through whole genome sequencing directly from sputum. Int J Infect Dis. 2017;62:44\u20136.","journal-title":"Int J Infect Dis."},{"issue":"1","key":"667_CR64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4068\/cmj.2018.54.1.1","volume":"54","author":"F Nurwidya","year":"2018","unstructured":"Nurwidya F, Handayani D, Burhan E, Yunus F. Molecular Diagnosis of Tuberculosis. Chonnam Med J. 2018;54(1):1\u20139.","journal-title":"Chonnam Med J."},{"key":"667_CR65","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12916-016-0598-2","volume":"14","author":"AA Witney","year":"2016","unstructured":"Witney AA, Cosgrove CA, Arnold A, Hinds J, Stoker NG, Butcher PD. Clinical use of whole genome sequencing for Mycobacterium tuberculosis. BMC Med. 2016;14:46.","journal-title":"BMC Med."},{"key":"667_CR66","doi-asserted-by":"publisher","first-page":"100582","DOI":"10.1016\/j.nmni.2019.100582","volume":"31","author":"F Zakham","year":"2019","unstructured":"Zakham F, Laurent S, Esteves Carreira AL, Corbaz A, Bertelli C, Masserey E, Nicod L, Greub G, Jaton K, Mazza-Stalder J, Opota O. Whole-genome sequencing for rapid, reliable and routine investigation of Mycobacterium tuberculosis transmission in local communities. New Microbes New Infect. 2019;31:100582.","journal-title":"New Microbes New Infect."},{"issue":"4","key":"667_CR67","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.ccm.2019.07.007","volume":"40","author":"MK Haas","year":"2019","unstructured":"Haas MK, Belknap RW. Diagnostic Tests for Latent Tuberculosis Infection. Clin Chest Med. 2019;40(4):829\u201337.","journal-title":"Clin Chest Med."},{"issue":"2","key":"667_CR68","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/ciw694","volume":"64","author":"DM Lewinsohn","year":"2017","unstructured":"Lewinsohn DM, Leonard MK, LoBue PA, Cohn DL, Daley CL, Desmond E, Keane J, Lewinsohn DA, Loeffler AM, Mazurek GH, O'Brien RJ, Pai M, Richeldi L, Salfinger M, Shinnick TM, Sterling TR, Warshauer DM, Woods GL. Official American Thoracic Society\/Infectious Diseases Society of America\/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children. Clin Infect Dis. 2017;64(2):e1\u2013e33.","journal-title":"Clin Infect Dis."},{"issue":"RR-5","key":"667_CR69","first-page":"1","volume":"59","author":"GH Mazurek","year":"2010","unstructured":"Mazurek GH, Jereb J, Vernon A, LoBue P, Goldberg S, Castro K, Committee IE. Centers for disease C. and prevention. updated guidelines for using interferon gamma release assays to detect mycobacterium tuberculosis infection - United States, 2010. MMWR Recomm Rep. 2010;59(RR-5):1\u201325.","journal-title":"MMWR Recomm Rep"},{"issue":"7","key":"667_CR70","doi-asserted-by":"publisher","first-page":"e00614","DOI":"10.1128\/JCM.00614-18","volume":"56","author":"ES Theel","year":"2018","unstructured":"Theel ES, Hilgart H, Breen-Lyles M, McCoy K, Flury R, Breeher LE, Wilson J, Sia IG, Whitaker JA, Clain J, Aksamit TR, Escalante P. Comparison of the QuantiFERON-TB Gold Plus and QuantiFERON-TB Gold In-Tube interferon gamma release assays in patients at risk for tuberculosis and in health care workers. J Clin Microbiol. 2018;56(7):e00614\u20138.","journal-title":"J Clin Microbiol."},{"issue":"6","key":"667_CR71","doi-asserted-by":"publisher","first-page":"724","DOI":"10.5588\/ijtld.12.0083","volume":"16","author":"D Mitchison","year":"2012","unstructured":"Mitchison D, Davies G. The chemotherapy of tuberculosis: past, present and future. Int J Tuberc Lung Dis. 2012;16(6):724\u201332.","journal-title":"Int J Tuberc Lung Dis."},{"key":"667_CR72","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/978-3-319-64371-7_11","volume":"1019","author":"AS Dean","year":"2017","unstructured":"Dean AS, Cox H, Zignol M. Epidemiology of Drug-Resistant Tuberculosis. Adv Exp Med Biol. 2017;1019:209\u201320.","journal-title":"Adv Exp Med Biol."},{"key":"667_CR73","unstructured":"WHO. End TB Strategy. 2015:2015."},{"issue":"6313","key":"667_CR74","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1126\/science.aaf8156","volume":"354","author":"JM Bryant","year":"2016","unstructured":"Bryant JM, Grogono DM, Rodriguez-Rincon D, Everall I, Brown KP, Moreno P, Verma D, Hill E, Drijkoningen J, Gilligan P, Esther CR, Noone PG, Giddings O, Bell SC, Thomson R, Wainwright CE, Coulter C, Pandey S, Wood ME, Stockwell RE, Ramsay KA, Sherrard LJ, Kidd TJ, Jabbour N, Johnson GR, Knibbs LD, Morawska L, Sly PD, Jones A, Bilton D, Laurenson I, Ruddy M, Bourke S, Bowler IC, Chapman SJ, Clayton A, Cullen M, Daniels T, Dempsey O, Denton M, Desai M, Drew RJ, Edenborough F, Evans J, Folb J, Humphrey H, Isalska B, Jensen-Fangel S, Jonsson B, Jones AM, Katzenstein TL, Lillebaek T, MacGregor G, Mayell S, Millar M, Modha D, Nash EF, O'Brien C, O'Brien D, Ohri C, Pao CS, Peckham D, Perrin F, Perry A, Pressler T, Prtak L, Qvist T, Robb A, Rodgers H, Schaffer K, Shafi N, van Ingen J, Walshaw M, Watson D, West N, Whitehouse J, Haworth CS, Harris SR, Ordway D, Parkhill J, Floto RA. Emergence and spread of a human-transmissible multidrug-resistant non-tuberculous mycobacterium. Science. 2016;354(6313):751\u20137.","journal-title":"Science"},{"issue":"1","key":"667_CR75","first-page":"107","volume":"119","author":"E Wolinsky","year":"1979","unstructured":"Wolinsky E. Nontuberculous mycobacteria and associated diseases. Am Rev Respir Dis. 1979;119(1):107\u201359.","journal-title":"Am Rev Respir Dis."},{"key":"667_CR76","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s13104-016-1928-3","volume":"9","author":"AS Hoza","year":"2016","unstructured":"Hoza AS, Mfinanga SG, Rodloff AC, Moser I, Konig B. Increased isolation of non-tuberculous mycobacteria among TB suspects in Northeastern, Tanzania: public health and diagnostic implications for control programmes. BMC Res Notes. 2016;9:109.","journal-title":"BMC Res Notes"},{"issue":"2","key":"667_CR77","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1179\/2047773214Y.0000000133","volume":"108","author":"S Jain","year":"2014","unstructured":"Jain S, Sankar MM, Sharma N, Singh S, Chugh TD. High prevalence of non-tuberculous mycobacterial disease among non-HIV infected individuals in a TB-endemic country--experience from a tertiary center in Delhi, India. Pathog Glob Health. 2014;108(2):118\u201322.","journal-title":"Pathog Glob Health"},{"issue":"6","key":"667_CR78","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1183\/09031936.00149212","volume":"42","author":"W Hoefsloot","year":"2013","unstructured":"Hoefsloot W, van Ingen J, Andrejak C, Angeby K, Bauriaud R, Bemer P, Beylis N, Boeree MJ, Cacho J, Chihota V, Chimara E, Churchyard G, Cias R, Daza R, Daley CL, Dekhuijzen PN, Domingo D, Drobniewski F, Esteban J, Fauville-Dufaux M, Folkvardsen DB, Gibbons N, Gomez-Mampaso E, Gonzalez R, Hoffmann H, Hsueh PR, Indra A, Jagielski T, Jamieson F, Jankovic M, Jong E, Keane J, Koh WJ, Lange B, Leao S, Macedo R, Mannsaker T, Marras TK, Maugein J, Milburn HJ, Mlinko T, Morcillo N, Morimoto K, Papaventsis D, Palenque E, Paez-Pena M, Piersimoni C, Polanova M, Rastogi N, Richter E, Ruiz-Serrano MJ, Silva A, da Silva MP, Simsek H, van Soolingen D, Szabo N, Thomson R, Tortola Fernandez T, Tortoli E, Totten SE, Tyrrell G, Vasankari T, Villar M, Walkiewicz R, Winthrop KL, Wagner D, Nontuberculous Mycobacteria Network European Trials G. The geographic diversity of non-tuberculous mycobacteria isolated from pulmonary samples: an NTM-NET collaborative study. Eur Respir J. 2013;42(6):1604\u201313.","journal-title":"Eur Respir J"},{"issue":"2","key":"667_CR79","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1093\/cid\/cix819","volume":"66","author":"NR Degner","year":"2018","unstructured":"Degner NR, Wang JY, Golub JE, Karakousis PC. Metformin Use Reverses the Increased Mortality Associated With Diabetes Mellitus During Tuberculosis Treatment. Clin Infect Dis. 2018;66(2):198\u2013205.","journal-title":"Clin Infect Dis."},{"issue":"2","key":"667_CR80","doi-asserted-by":"publisher","first-page":"e0007083","DOI":"10.1371\/journal.pntd.0007083","volume":"13","author":"SL Baldwin","year":"2019","unstructured":"Baldwin SL, Larsen SE, Ordway D, Cassell G, Coler RN. The complexities and challenges of preventing and treating non-tuberculous mycobacterial diseases. PLoS Negl Trop Dis. 2019;13(2):e0007083.","journal-title":"PLoS Negl Trop Dis."},{"issue":"8","key":"667_CR81","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1136\/thx.2006.070797","volume":"62","author":"TK Marras","year":"2007","unstructured":"Marras TK, Chedore P, Ying AM, Jamieson F. Isolation prevalence of pulmonary non-tuberculous mycobacteria in Ontario, 1997 2003. Thorax. 2007;62(8):661\u20136.","journal-title":"Thorax."},{"key":"667_CR82","doi-asserted-by":"publisher","first-page":"234","DOI":"10.3389\/fimmu.2019.00234","volume":"10","author":"G Abate","year":"2019","unstructured":"Abate G, Hamzabegovic F, Eickhoff CS, Hoft DF. BCG Vaccination Induces M. avium and M. abscessus Cross-Protective Immunity. Front Immunol. 2019;10:234.","journal-title":"Front Immunol"},{"issue":"2","key":"667_CR83","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1378\/chest.75.2.120","volume":"75","author":"CH Ahn","year":"1979","unstructured":"Ahn CH, Lowell JR, Onstad GD, Shuford EH, Hurst GA. A demographic study of disease due to Mycobacterium kansasii or M intracellulare-avium in Texas. Chest. 1979;75(2):120\u20135.","journal-title":"Chest."},{"issue":"8","key":"667_CR84","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1093\/cid\/ciy241","volume":"67","author":"A Kontturi","year":"2018","unstructured":"Kontturi A, Soini H, Ollgren J, Salo E. Increase in Childhood Nontuberculous Mycobacterial Infections After Bacille Calmette-Guerin Coverage Drop: A Nationwide, Population-Based Retrospective Study, Finland, 1995-2016. Clin Infect Dis. 2018;67(8):1256\u201361.","journal-title":"Clin Infect Dis."},{"issue":"5","key":"667_CR85","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/0962-8479(94)90080-9","volume":"75","author":"L Trnka","year":"1994","unstructured":"Trnka L, Dankova D, Svandova E. Six years\u2019 experience with the discontinuation of BCG vaccination. 4. Protective effect of BCG vaccination against the Mycobacterium avium intracellulare complex. Tuber Lung Dis. 1994;75(5):348\u201352.","journal-title":"Tuber Lung Dis."},{"issue":"7","key":"667_CR86","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1164\/rccm.201002-0310OC","volume":"182","author":"DR Prevots","year":"2010","unstructured":"Prevots DR, Shaw PA, Strickland D, Jackson LA, Raebel MA, Blosky MA, Montes de Oca R, Shea YR, Seitz AE, Holland SM, Olivier KN. Nontuberculous mycobacterial lung disease prevalence at four integrated health care delivery systems. Am J Respir Crit Care Med. 2010;182(7):970\u20136.","journal-title":"Am J Respir Crit Care Med."},{"issue":"2","key":"667_CR87","doi-asserted-by":"publisher","first-page":"294","DOI":"10.3201\/eid1602.090675","volume":"16","author":"CC Lai","year":"2010","unstructured":"Lai CC, Tan CK, Chou CH, Hsu HL, Liao CH, Huang YT, Yang PC, Luh KT, Hsueh PR. Increasing incidence of non-tuberculous mycobacteria, Taiwan, 2000-2008. Emerg Infect Dis. 2010;16(2):294\u20136.","journal-title":"Emerg Infect Dis."},{"issue":"6","key":"667_CR88","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1007\/s10096-011-1155-8","volume":"30","author":"CC Lai","year":"2011","unstructured":"Lai CC, Tan CK, Lin SH, Liu WL, Liao CH, Huang YT, Hsueh PR. Clinical significance of non-tuberculous mycobacteria isolates in elderly Taiwanese patients. Eur J Clin Microbiol Infect Dis. 2011;30(6):779\u201383.","journal-title":"Eur J Clin Microbiol Infect Dis."},{"key":"667_CR89","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1186\/1471-2458-10-612","volume":"10","author":"JE Moore","year":"2010","unstructured":"Moore JE, Kruijshaar ME, Ormerod LP, Drobniewski F, Abubakar I. Increasing reports of non-tuberculous mycobacteria in England, Wales and Northern Ireland, 1995-2006. BMC Public Health. 2010;10:612.","journal-title":"BMC Public Health."},{"key":"667_CR90","doi-asserted-by":"publisher","first-page":"6196532","DOI":"10.1155\/2019\/6196532","volume":"2019","author":"B Ayelign","year":"2019","unstructured":"Ayelign B, Negash M, Genetu M, Wondmagegn T, Shibabaw T. Immunological Impacts of Diabetes on the Susceptibility of Mycobacterium tuberculosis. J Immunol Res. 2019;2019:6196532.","journal-title":"J Immunol Res."},{"key":"667_CR91","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/1741-7015-9-81","volume":"9","author":"MA Baker","year":"2011","unstructured":"Baker MA, Harries AD, Jeon CY, Hart JE, Kapur A, Lonnroth K, Ottmani SE, Goonesekera SD, Murray MB. The impact of diabetes on tuberculosis treatment outcomes: a systematic review. BMC Med. 2011;9:81.","journal-title":"BMC Med."},{"issue":"1","key":"667_CR92","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/imm.12762","volume":"152","author":"NP Kumar","year":"2017","unstructured":"Kumar NP, Babu S. Influence of diabetes mellitus on immunity to human tuberculosis. Immunology. 2017;152(1):13\u201324.","journal-title":"Immunology."},{"issue":"3","key":"667_CR93","doi-asserted-by":"publisher","first-page":"528","DOI":"10.4269\/ajtmh.16-0104","volume":"95","author":"T Bridson","year":"2016","unstructured":"Bridson T, Govan B, Ketheesan N, Norton R. Overrepresentation of Diabetes in Soft Tissue Nontuberculous Mycobacterial Infections. Am J Trop Med Hyg. 2016;95(3):528\u201330.","journal-title":"Am J Trop Med Hyg."},{"issue":"4","key":"667_CR94","doi-asserted-by":"publisher","first-page":"141A","DOI":"10.1378\/chest.2250163","volume":"148","author":"T Pande","year":"2015","unstructured":"Pande T, Pai M, Denkinger C. Use of Chest X-rays in 22 High Tuberculosis Burden Countries. CHEST. 2015;148(4):141A.","journal-title":"CHEST."},{"issue":"1","key":"667_CR95","first-page":"7","volume":"58","author":"Centers for Disease C. and Prevention","year":"2009","unstructured":"Centers for Disease C. and Prevention. Updated guidelines for the use of nucleic acid amplification tests in the diagnosis of tuberculosis. MMWR Morb Mortal Wkly Rep. 2009;58(1):7\u201310.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"667_CR96","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.ajic.2004.08.003","volume":"33","author":"MK Leonard","year":"2005","unstructured":"Leonard MK, Osterholt D, Kourbatova EV, Del Rio C, Wang W, Blumberg HM. How many sputum specimens are necessary to diagnose pulmonary tuberculosis? Am J Infect Control. 2005;33(1):58\u201361.","journal-title":"Am J Infect Control."},{"issue":"1","key":"667_CR97","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/s12916-017-0955-9","volume":"15","author":"PPJ Phillips","year":"2017","unstructured":"Phillips PPJ, Mendel CM, Nunn AJ, McHugh TD, Crook AM, Hunt R, Bateson A, Gillespie SH. A comparison of liquid and solid culture for determining relapse and durable cure in phase III TB trials for new regimens. BMC Med. 2017;15(1):207.","journal-title":"BMC Med."},{"issue":"3","key":"667_CR98","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/S0272-5231(02)00020-5","volume":"23","author":"A Catanzaro","year":"2002","unstructured":"Catanzaro A. Diagnosis, differentiating colonization, infection, and disease. Clin Chest Med. 2002;23(3):599\u2013601, vi.","journal-title":"Clin Chest Med"},{"key":"667_CR99","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jctube.2018.07.003","volume":"13","author":"A Scohy","year":"2018","unstructured":"Scohy A, Gohy S, Mathys V, Sapriel G, Toussaint L, Bressant F, Zitouni A, Teylaert MN, Vander Meeren MC, Colmant A, Simon A, Perry JD, Lebecque P, Andre E. Comparison of the RGM medium and the mycobacterial growth indicator tube automated system for isolation of non-tuberculous mycobacteria from sputum samples of cystic fibrosis patients in Belgium. J Clin Tuberc Other Mycobact Dis. 2018;13:1\u20134.","journal-title":"J Clin Tuberc Other Mycobact Dis."},{"issue":"1","key":"667_CR100","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12890-019-0781-2","volume":"19","author":"D Stephenson","year":"2019","unstructured":"Stephenson D, Perry A, Appleby MR, Lee D, Davison J, Johnston A, Jones AL, Nelson A, Bourke SJ, Thomas MF, De Soyza A, Lordan JL, Lumb J, Robb AE, Samuel JR, Walton KE, Perry JD. An evaluation of methods for the isolation of non-tuberculous mycobacteria from patients with cystic fibrosis, bronchiectasis and patients assessed for lung transplantation. BMC Pulm Med. 2019;19(1):19.","journal-title":"BMC Pulm Med."},{"key":"667_CR101","doi-asserted-by":"publisher","first-page":"e00107","DOI":"10.1016\/j.plabm.2018.e00107","volume":"12","author":"GS Bhalla","year":"2018","unstructured":"Bhalla GS, Sarao MS, Kalra D, Bandyopadhyay K, John AR. Methods of phenotypic identification of non-tuberculous mycobacteria. Pract Lab Med. 2018;12:e00107.","journal-title":"Pract Lab Med."},{"issue":"3","key":"667_CR102","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.diagmicrobio.2005.02.014","volume":"52","author":"DF Moore","year":"2005","unstructured":"Moore DF, Guzman JA, Mikhail LT. Reduction in turn-around time for laboratory diagnosis of pulmonary tuberculosis by routine use of a nucleic acid amplification test. Diagn Microbiol Infect Dis. 2005;52(3):247\u201354.","journal-title":"Diagn Microbiol Infect Dis."},{"issue":"3","key":"667_CR103","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1378\/chest.06-2959","volume":"132","author":"RL Guerra","year":"2007","unstructured":"Guerra RL, Hooper NM, Baker JF, Alborz R, Armstrong DT, Maltas G, Kiehlbauch JA, Dorman SE. Use of the amplified mycobacterium tuberculosis direct test in a public health laboratory: test performance and impact on clinical care. Chest. 2007;132(3):946\u201351.","journal-title":"Chest."},{"issue":"3","key":"667_CR104","doi-asserted-by":"publisher","first-page":"380","DOI":"10.3201\/eid1303.061400","volume":"13","author":"NS Shah","year":"2007","unstructured":"Shah NS, Wright A, Bai GH, Barrera L, Boulahbal F, Martin-Casabona N, Drobniewski F, Gilpin C, Havelkova M, Lepe R, Lumb R, Metchock B, Portaels F, Rodrigues MF, Rusch-Gerdes S, Van Deun A, Vincent V, Laserson K, Wells C, Cegielski JP. Worldwide emergence of extensively drug-resistant tuberculosis. Emerg Infect Dis. 2007;13(3):380\u20137.","journal-title":"Emerg Infect Dis."},{"issue":"4","key":"667_CR105","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1086\/505877","volume":"194","author":"M Zignol","year":"2006","unstructured":"Zignol M, Hosseini MS, Wright A, Weezenbeek CL, Nunn P, Watt CJ, Williams BG, Dye C. Global incidence of multidrug-resistant tuberculosis. J Infect Dis. 2006;194(4):479\u201385.","journal-title":"J Infect Dis."},{"issue":"3","key":"667_CR106","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1128\/JCM.44.3.688-692.2006","volume":"44","author":"S Rusch-Gerdes","year":"2006","unstructured":"Rusch-Gerdes S, Pfyffer GE, Casal M, Chadwick M, Siddiqi S. Multicenter laboratory validation of the BACTEC MGIT 960 technique for testing susceptibilities of Mycobacterium tuberculosis to classical second-line drugs and newer antimicrobials. J Clin Microbiol. 2006;44(3):688\u201392.","journal-title":"J Clin Microbiol."},{"issue":"3","key":"667_CR107","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1586\/14737159.6.3.423","volume":"6","author":"M Pai","year":"2006","unstructured":"Pai M, Kalantri S, Dheda K. New tools and emerging technologies for the diagnosis of tuberculosis: part II. Active tuberculosis and drug resistance. Expert Rev Mol Diagn. 2006;6(3):423\u201332.","journal-title":"Expert Rev Mol Diagn."},{"issue":"12","key":"667_CR108","doi-asserted-by":"publisher","first-page":"e01388","DOI":"10.1128\/MRA.01388-18","volume":"8","author":"S Shanmugam","year":"2019","unstructured":"Shanmugam S, Kumar N, Nair D, Natrajan M, Tripathy SP, Peacock SJ, Swaminathan S, Ranganathan UD. Genome sequencing of polydrug-, multidrug-, and extensively drug-resistant mycobacterium tuberculosis strains from South India. Microbiol Resour Announc. 2019;8(12):e01388\u201318.","journal-title":"Microbiol Resour Announc."},{"key":"667_CR109","doi-asserted-by":"publisher","first-page":"695","DOI":"10.2147\/IDR.S158953","volume":"11","author":"J Kostera","year":"2018","unstructured":"Kostera J, Leckie G, Abravaya K, Wang H. Performance of the Abbott RealTime MTB RIF\/INH resistance assay when used to test Mycobacterium tuberculosis specimens from Bangladesh. Infect Drug Resist. 2018;11:695\u20139.","journal-title":"Infect Drug Resist."},{"issue":"9","key":"667_CR110","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.2217\/fmb.14.60","volume":"9","author":"J van Ingen","year":"2014","unstructured":"van Ingen J, Kuijper EJ. Drug susceptibility testing of non-tuberculous mycobacteria. Future Microbiol. 2014;9(9):1095\u2013110.","journal-title":"Future Microbiol."},{"issue":"3","key":"667_CR111","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.ijantimicag.2012.10.021","volume":"41","author":"CW Huang","year":"2013","unstructured":"Huang CW, Chen JH, Hu ST, Huang WC, Lee YC, Huang CC, Shen GH. Synergistic activities of tigecycline with clarithromycin or amikacin against rapidly growing mycobacteria in Taiwan. Int J Antimicrob Agents. 2013;41(3):218\u201323.","journal-title":"Int J Antimicrob Agents."},{"issue":"10","key":"667_CR112","doi-asserted-by":"publisher","first-page":"6561","DOI":"10.1128\/AAC.01158-15","volume":"59","author":"A Kaushik","year":"2015","unstructured":"Kaushik A, Makkar N, Pandey P, Parrish N, Singh U, Lamichhane G. Carbapenems and Rifampin Exhibit Synergy against Mycobacterium tuberculosis and Mycobacterium abscessus. Antimicrob Agents Chemother. 2015;59(10):6561\u20137.","journal-title":"Antimicrob Agents Chemother."},{"key":"667_CR113","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s41182-019-0154-9","volume":"47","author":"KK Htwe","year":"2019","unstructured":"Htwe KK, Kyaw NTT, Kumar AMV, Kyaw KWY, Oo MM, Thwin T, Saw S, Aung ST. Pre-treatment loss to follow-up and treatment delay among bacteriologically-confirmed tuberculosis patients diagnosed in Mandalay Region. Myanmar. Trop Med Health. 2019;47:30.","journal-title":"Myanmar. Trop Med Health."},{"issue":"6","key":"667_CR114","doi-asserted-by":"publisher","first-page":"e004818","DOI":"10.1136\/bmjopen-2014-004818","volume":"4","author":"J Virenfeldt","year":"2014","unstructured":"Virenfeldt J, Rudolf F, Camara C, Furtado A, Gomes V, Aaby P, Petersen E, Wejse C. Treatment delay affects clinical severity of tuberculosis: a longitudinal cohort study. BMJ Open. 2014;4(6):e004818.","journal-title":"BMJ Open."},{"issue":"4","key":"667_CR115","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1183\/13993003.00432-2015","volume":"46","author":"JA Caminero","year":"2015","unstructured":"Caminero JA, Scardigli A. Classification of antituberculosis drugs: a new proposal based on the most recent evidence. Eur Respir J. 2015;46(4):887\u201393.","journal-title":"Eur Respir J."},{"issue":"7","key":"667_CR116","doi-asserted-by":"publisher","first-page":"e147","DOI":"10.1093\/cid\/ciw376","volume":"63","author":"P Nahid","year":"2016","unstructured":"Nahid P, Dorman SE, Alipanah N, Barry PM, Brozek JL, Cattamanchi A, Chaisson LH, Chaisson RE, Daley CL, Grzemska M, Higashi JM, Ho CS, Hopewell PC, Keshavjee SA, Lienhardt C, Menzies R, Merrifield C, Narita M, O'Brien R, Peloquin CA, Raftery A, Saukkonen J, Schaaf HS, Sotgiu G, Starke JR, Migliori GB, Vernon A. Official American thoracic society\/centers for disease control and prevention\/infectious diseases society of America clinical practice guidelines: treatment of drug-susceptible tuberculosis. Clin Infect Dis. 2016;63(7):e147\u201395.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"667_CR117","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.ccm.2019.07.006","volume":"40","author":"BS Zha","year":"2019","unstructured":"Zha BS, Nahid P. Treatment of Drug-Susceptible Tuberculosis. Clin Chest Med. 2019;40(4):763\u201374.","journal-title":"Clin Chest Med."},{"issue":"3","key":"667_CR118","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1007\/s11904-012-0129-5","volume":"9","author":"G Meintjes","year":"2012","unstructured":"Meintjes G, Scriven J, Marais S. Management of the immune reconstitution inflammatory syndrome. Curr HIV\/AIDS Rep. 2012;9(3):238\u201350.","journal-title":"Curr HIV\/AIDS Rep."},{"issue":"6","key":"667_CR119","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1097\/COH.0000000000000502","volume":"13","author":"NF Walker","year":"2018","unstructured":"Walker NF, Stek C, Wasserman S, Wilkinson RJ, Meintjes G. The tuberculosis-associated immune reconstitution inflammatory syndrome: recent advances in clinical and pathogenesis research. Curr Opin HIV AIDS. 2018;13(6):512\u201321.","journal-title":"Curr Opin HIV AIDS."},{"key":"667_CR120","unstructured":"WHO. Guidelines on Post-Exposure Prophylaxis for HIV and the Use of Co-Trimoxazole Prophylaxis for HIV-Related Infections Among Adults, Adolescents and Children: Recommendations for a Public Health Approach: December 2014 supplement to the 2013 consolidated guidelines on the use of anti-retroviral drugs for treating and preventing HIV infection. Geneva: WHO press; 2014."},{"issue":"5","key":"667_CR121","doi-asserted-by":"publisher","first-page":"933","DOI":"10.3904\/kjim.2017.249","volume":"33","author":"YJ Lee","year":"2018","unstructured":"Lee YJ, Han SK, Park JH, Lee JK, Kim DK, Chung HS, Heo EY. The effect of metformin on culture conversion in tuberculosis patients with diabetes mellitus. Korean J Intern Med. 2018;33(5):933\u201340.","journal-title":"Korean J Intern Med."},{"issue":"7","key":"667_CR122","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1007\/s10096-018-3242-6","volume":"37","author":"Y Ma","year":"2018","unstructured":"Ma Y, Pang Y, Shu W, Liu YH, Ge QP, Du J, Li L, Gao WW. Metformin reduces the relapse rate of tuberculosis patients with diabetes mellitus: experiences from 3-year follow-up. Eur J Clin Microbiol Infect Dis. 2018;37(7):1259\u201363.","journal-title":"Eur J Clin Microbiol Infect Dis."},{"issue":"1","key":"667_CR123","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1186\/s12879-019-4548-4","volume":"19","author":"X Yu","year":"2019","unstructured":"Yu X, Li L, Xia L, Feng X, Chen F, Cao S, Wei X. Impact of metformin on the risk and treatment outcomes of tuberculosis in diabetics: a systematic review. BMC Infect Dis. 2019;19(1):859.","journal-title":"BMC Infect Dis."},{"key":"667_CR124","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3389\/fmed.2017.00171","volume":"4","author":"A Kolloli","year":"2017","unstructured":"Kolloli A, Subbian S. Host-Directed Therapeutic Strategies for Tuberculosis. Front Med (Lausanne). 2017;4:171.","journal-title":"Front Med (Lausanne)"},{"key":"667_CR125","doi-asserted-by":"publisher","first-page":"435","DOI":"10.3389\/fmicb.2020.00435","volume":"11","author":"N Naicker","year":"2020","unstructured":"Naicker N, Sigal A, Naidoo K. Metformin as Host-Directed Therapy for TB Treatment: Scoping Review. Front Microbiol. 2020;11:435.","journal-title":"Front Microbiol."},{"key":"667_CR126","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.tube.2019.02.004","volume":"115","author":"WW Yew","year":"2019","unstructured":"Yew WW, Chang KC, Chan DP, Zhang Y. Metformin as a host-directed therapeutic in tuberculosis: Is there a promise? Tuberculosis (Edinb). 2019;115:76\u201380.","journal-title":"Tuberculosis (Edinb)"},{"key":"667_CR127","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.micpath.2019.03.003","volume":"130","author":"P Baindara","year":"2019","unstructured":"Baindara P. Host-directed therapies to combat tuberculosis and associated non-communicable diseases. Microb Pathog. 2019;130:156\u201368.","journal-title":"Microb Pathog."},{"key":"667_CR128","doi-asserted-by":"crossref","unstructured":"Young C, Walzl G, Du Plessis N. Therapeutic host-directed strategies to improve outcome in tuberculosis. Mucosal Immunol. 2019.","DOI":"10.1038\/s41385-019-0226-5"},{"issue":"5","key":"667_CR129","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1164\/rccm.201001-0077OC","volume":"182","author":"A Van Deun","year":"2010","unstructured":"Van Deun A, Maug AK, Salim MA, Das PK, Sarker MR, Daru P, Rieder HL. Short, highly effective, and inexpensive standardized treatment of multidrug-resistant tuberculosis. Am J Respir Crit Care Med. 2010;182(5):684\u201392.","journal-title":"Am J Respir Crit Care Med."},{"key":"667_CR130","volume-title":"Technical report on critical concentrations for TB drug susceptibility testing of medicines used in the treatment of drug-resistant TB","author":"WHO","year":"2018","unstructured":"WHO. Technical report on critical concentrations for TB drug susceptibility testing of medicines used in the treatment of drug-resistant TB. 2018. https:\/\/www.who.int\/tb\/publications\/2018\/WHO_technical_report_concentrations_TB_drug_susceptibility\/en\/. Accessed."},{"issue":"4","key":"667_CR131","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.ccm.2019.08.001","volume":"40","author":"EH Ignatius","year":"2019","unstructured":"Ignatius EH, Dooley KE. New Drugs for the Treatment of Tuberculosis. Clin Chest Med. 2019;40(4):811\u201327.","journal-title":"Clin Chest Med."},{"issue":"4","key":"667_CR132","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1183\/20734735.027218","volume":"14","author":"M Lu","year":"2018","unstructured":"Lu M, Fitzgerald D, Karpelowsky J, Selvadurai H, Pandit C, Robinson P, Marais BJ. Surgery in non-tuberculous mycobacteria pulmonary disease. Breathe (Sheff). 2018;14(4):288\u2013301.","journal-title":"Breathe (Sheff)."},{"issue":"Suppl 2","key":"667_CR133","doi-asserted-by":"publisher","first-page":"ii1","DOI":"10.1136\/thoraxjnl-2017-210927","volume":"72","author":"CS Haworth","year":"2017","unstructured":"Haworth CS, Banks J, Capstick T, Fisher AJ, Gorsuch T, Laurenson IF, Leitch A, Loebinger MR, Milburn HJ, Nightingale M, Ormerod P, Shingadia D, Smith D, Whitehead N, Wilson R, Floto RA. British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD). Thorax. 2017;72(Suppl 2):ii1\u2013ii64.","journal-title":"Thorax"},{"issue":"5","key":"667_CR134","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.jcf.2019.05.013","volume":"18","author":"B Banaschewski","year":"2019","unstructured":"Banaschewski B, Verma D, Pennings LJ, Zimmerman M, Ye Q, Gadawa J, Dartois V, Ordway D, van Ingen J, Ufer S, Stapleton K, Hofmann T. Clofazimine inhalation suspension for the aerosol treatment of pulmonary non-tuberculous mycobacterial infections. J Cyst Fibros. 2019;18(5):714\u201320.","journal-title":"J Cyst Fibros."},{"issue":"6","key":"667_CR135","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1111\/j.1348-0421.2010.00221.x","volume":"54","author":"HY Kim","year":"2010","unstructured":"Kim HY, Kim BJ, Kook Y, Yun YJ, Shin JH, Kim BJ, Kook YH. Mycobacterium massiliense is differentiated from Mycobacterium abscessus and Mycobacterium bolletii by erythromycin ribosome methyltransferase gene (erm) and clarithromycin susceptibility patterns. Microbiol Immunol. 2010;54(6):347\u201353.","journal-title":"Microbiol Immunol."},{"issue":"3","key":"667_CR136","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1164\/rccm.201003-0395OC","volume":"183","author":"WJ Koh","year":"2011","unstructured":"Koh WJ, Jeon K, Lee NY, Kim BJ, Kook YH, Lee SH, Park YK, Kim CK, Shin SJ, Huitt GA, Daley CL, Kwon OJ. Clinical significance of differentiation of Mycobacterium massiliense from Mycobacterium abscessus. Am J Respir Crit Care Med. 2011;183(3):405\u201310.","journal-title":"Am J Respir Crit Care Med."},{"issue":"1","key":"667_CR137","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.ccm.2014.11.001","volume":"36","author":"EF Egelund","year":"2015","unstructured":"Egelund EF, Fennelly KP, Peloquin CA. Medications and monitoring in non-tuberculous mycobacteria infections. Clin Chest Med. 2015;36(1):55\u201366.","journal-title":"Clin Chest Med."},{"issue":"1","key":"667_CR138","first-page":"53","volume":"8","author":"S Luca","year":"2013","unstructured":"Luca S, Mihaescu T. History of BCG Vaccine. Maedica (Buchar). 2013;8(1):53\u20138.","journal-title":"Maedica (Buchar)."},{"issue":"5","key":"667_CR139","doi-asserted-by":"publisher","first-page":"TBTB2\u20130015\u20132016","DOI":"10.1128\/microbiolspec.TBTB2-0015-2016","volume":"4","author":"M Hatherill","year":"2016","unstructured":"Hatherill M, Tait D, McShane H. Clinical testing of tuberculosis vaccine candidates. Microbiol Spectr. 2016;4(5):TBTB2\u20130015\u20132016.","journal-title":"Microbiol Spectr"},{"key":"667_CR140","doi-asserted-by":"publisher","first-page":"316","DOI":"10.3389\/fimmu.2020.00316","volume":"11","author":"SHE Kaufmann","year":"2020","unstructured":"Kaufmann SHE. Vaccination Against Tuberculosis: Revamping BCG by Molecular Genetics Guided by Immunology. Front Immunol. 2020;11:316.","journal-title":"Front Immunol."},{"key":"667_CR141","doi-asserted-by":"crossref","unstructured":"Li J, Zhao A, Tang J, Wang G, Shi Y, Zhan L, Qin C. Tuberculosis vaccine development: from classic to clinical candidates. Eur J Clin Microbiol Infect Dis. 2020.","DOI":"10.1007\/s10096-020-03843-6"},{"issue":"1","key":"667_CR142","doi-asserted-by":"publisher","first-page":"00100","DOI":"10.1128\/CMR.00100-19","volume":"33","author":"SB Sable","year":"2019","unstructured":"Sable SB, Posey JE, Scriba TJ. Tuberculosis vaccine development: progress in clinical evaluation. Clin Microbiol Rev. 2019;33(1):00100\u201319.","journal-title":"Clin Microbiol Rev."},{"issue":"2","key":"667_CR143","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/0041-3879(85)90076-5","volume":"66","author":"IM Orme","year":"1985","unstructured":"Orme IM, Collins FM. Prophylactic effect in mice of BCG vaccination against non-tuberculous mycobacterial infections. Tubercle. 1985;66(2):117\u201320.","journal-title":"Tubercle."},{"issue":"1","key":"667_CR144","first-page":"139.135","volume":"202","author":"SE Larsen","year":"2019","unstructured":"Larsen SE, Reese VA, Pecor TI, Brewer G, Berube B, Njikan S, Parish T, Henao-Tamayo M, Baldwin SL, Coler RN. Subunit vaccine candidate with adjuvant confers protection against clinical Mycobacterium avium in wild type and immunocompromised mouse models. J Immunol. 2019;202(1):139.135.","journal-title":"J Immunol."},{"issue":"2 Pt 2","key":"667_CR145","doi-asserted-by":"publisher","first-page":"e13","DOI":"10.1016\/j.lpm.2017.01.015","volume":"46","author":"A Matteelli","year":"2017","unstructured":"Matteelli A, Sulis G, Capone S, D'Ambrosio L, Migliori GB, Getahun H. Tuberculosis elimination and the challenge of latent tuberculosis. Presse Med. 2017;46(2 Pt 2):e13\u201321.","journal-title":"Presse Med."}],"container-title":["Journal of Biomedical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12929-020-00667-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12929-020-00667-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12929-020-00667-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,16]],"date-time":"2021-06-16T19:32:17Z","timestamp":1623871937000},"score":1,"resource":{"primary":{"URL":"https:\/\/jbiomedsci.biomedcentral.com\/articles\/10.1186\/s12929-020-00667-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,17]]},"references-count":145,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["667"],"URL":"https:\/\/doi.org\/10.1186\/s12929-020-00667-6","relation":{},"ISSN":["1423-0127"],"issn-type":[{"value":"1423-0127","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,17]]},"assertion":[{"value":"29 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"74"}}